Wockhardt Ltd. — Zaynich (cefepime/zidebactam)

for complicated urinary tract infections

NDA

FDA approved Zaynich (cefepime + zidebactam) for adults with complicated urinary tract infections. Wockhardt's first FDA approval — gives clinicians a novel beta-lactam-enhancer combination for multidrug-resistant gram-negative cUTI.